Starts in:
1 BACB General CEUs $30 57 min On-Demand

General CEU: From Lab to Launch: Strategic Approaches to Drug Distribution and Market Access

From Lab to Launch: Strategic Approaches to Drug Distribution and Market Access is the kind of topic that looks straightforward until it collides with the speed, ambiguity, and competing demands of case conceptualization, intervention design, staff training, and literature-informed problem solving. In From Lab to Launch: Strategic Approaches to Drug Distribution and Market Access, for this course, the practical stakes show up in stronger conceptual consistency and better translational decision making, not in abstract discussion alone.

Provider: BehaviorLive — via AVBCC

Take This Course →
OR
FREE CEUs

Get 60+ CEUs Free in The ABA Clubhouse

Including ethics, supervision, and topics like this one. New live CEU every Wednesday.

Join Free →
Your CEUs are scattered everywhere.Between what you earn here, your employer, conferences, and other providers — it adds up fast. Upload any certificate and just know where you stand.
Try Free for 30 Days

Course Description

As the pharmaceutical landscape becomes increasingly complex, selecting the right go-to-market (GTM) strategy and distribution model is critical to ensuring the successful launch and sustained access of new therapies. This session will explore how pharma companies can align commercialization strategies with evolving payer dynamics, provider expectations, and patient needs. Industry leaders will share real-world insights on evaluating distribution channels—including specialty pharmacy, specialty distribution, limited distribution networks (LDNs), and hybrid models—and the strategic considerations that drive these decisions. Particular attention will be given to the use of limited distribution models, including their benefits in managing complex therapies and ensuring quality of care, as well as their potential impact on provider workflows and continuity of care for patients. Attendees will gain a deeper understanding of how distribution choices influence not only market access and operational efficiency but also patient experience and long-term product performance. Join this dynamic panel discussion that highlights best practices, lessons learned, and emerging trends shaping the future of pharmaceutical distribution and GTM planning.

What You'll Learn

  1. Explain the key concepts and principles discussed in From Lab to Launch: Strategic Approaches to Drug Distribution and Market Access.
  2. Apply how the themes presented in From Lab to Launch: Strategic Approaches to Drug Distribution and Market Access relate to current behavior analytic practice.
  3. Compare the practical implications of From Lab to Launch: Strategic Approaches to Drug Distribution and Market Access for behavior analysts in professional settings.

CEU Credits Earned

Certification BodyCreditsType
BACB 1 General

About the Instructor

MR
Michael Reff
Founder & Executive Director
📚 Browse All 60+ Free CEUs — ethics, supervision & clinical topics in The ABA Clubhouse

Research Explore the Evidence

Dig into the research behind this topic — plain-English summaries written for BCBAs.

ID Mental Health and Adaptive Screeners

244 research articles with practitioner takeaways

View Research →

Genetic Syndrome Behavior Profiles

200 research articles with practitioner takeaways

View Research →

BST for Staff and Parent Training

156 research articles with practitioner takeaways

View Research →
CEU Buddy

No scramble. No surprises.

You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.

Upload a certificate, everything else is automatic Works with any ACE provider $7/mo to protect $1,000+ in earned CEUs
Try It Free for 30 Days →

No credit card required. Cancel anytime.

Clinical Disclaimer

All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.

60+ Free CEUs — ethics, supervision & clinical topics